Folliculocentric squamous cell carcinoma with tricholemmal differentiation: A reappraisal of tricholemmal carcinoma

Clinical and Experimental Dermatology

Volumn 37, Issue 5, 2012, Pages 484-491

  Misago, Noriyuki ^a   Toda, S ^b   Narisawa, Y ^a  

^a SAGA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 17; GLYCOGEN;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BOWEN DISEASE; CANCER PATIENT; CELL COMPOSITION; CELL DIFFERENTIATION; CELL GROWTH; CELL INFILTRATION; CLEAR CELL CARCINOMA; COLUMNAR EPITHELIUM; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; FOLLICULOCENTRIC SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; HAIR FOLLICLE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN CARCINOMA; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; TRICHILEMMOMA; TRICHOLEMMAL CARCINOMA; TUMOR VOLUME;

AGED; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MIDDLE AGED; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862869073     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2012.04366.x     Document Type: Article

References (25)

1. Diaz-Cascajo C, Borghi S, Weyers W, Bastida-Inarrea J. Follicular squamous cell carcinoma of the skin: a poorly recognized neoplasm arising from the wall of hair follicles. J Cutan Pathol 2004; 31: 19-25. (Pubitemid 38130272)
2. Misago N, Inoue T, Toda S, Narisawa Y. Infundibular (follicular) and infundibulocystic squamous cell carcinoma: a clinicopathological and immunohistochemical study. Am J Dermatopathol 2011; 33: 687-94.
3. Headington JT. Tricholemmal carcinoma. J Cutan Pathol 1992; 19: 83-4.
4. Swanson PE, Marrogi AJ, Williams DJ et al. Tricholemmal carcinoma: clinicopathologic study of 10 cases. J Cutan Pathol 1992; 19: 100-9.
5. Boscaino A, Terracciano LM, Donofrio V et al. Tricholemmal carcinoma: a study of seven cases. J Cutan Pathol 1992; 19: 94-9.
6. Reis JP, Tellechea O, Cunha MF, Baptista AP. Tricholemmal carcinoma: review of 8 cases. J Cutan Pathol 1993; 20: 44-9.
7. Wong T, Suster S. Tricholemmal carcinoma: a clincopathologic study of 13 cases. Am J Dermatopathol 1994; 16: 463-73. (Pubitemid 24323353)
8. Misago N, Ackerman AB. Tricholemmal carcinoma? Dermatopathol Pract Concept 1999; 5: 205-6.
9. Cribier B, Lipsker D, Grosshans E. Eccrine porocarcinoma, tricholemmal carcinoma and multiple squamous cell carcinomas in a single patient. Eur J Dermatol 1999; 9: 483-6. (Pubitemid 29475981)
10. Allee JE, Cotsarelis G, Solky B, Cook JL. Multiply recurrent trichilemmal carcinoma with perineural invasion and cytokeratin 17 positivity. Dermatol Surg 2003; 29: 886-9. (Pubitemid 36927518)
11. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification (part one). J Cutan Pathol 2006; 33: 191-206.
12. Pozo L, Diaz-Cano SJ. Trichilemmal carcinoma with neuroendocrine differentiation. Clin Exp Dermatol 2008; 33: 128-31. (Pubitemid 351197191)
13. Dalton SR, LeBoit PE. Squamous cell carcinoma with clear cells: how often is there evidence of tricholemmal differentiation? Am J Dermatopathol 2008; 30: 333-9.
14. Kulahci Y, Oksuz S, Kucukodaci Z et al. Multiple recurrence of trichilemmal carcinoma of the scalp in a young adult. Dermatol Surg 2010; 36: 551-4.
15. Misago N, Toda S, Narisawa Y. Tricholemmoma and clear cell squamous cell carcinoma (associated with Bowen's disease): Immunohistochemical profile in comparison to normal hair follicles. Am J Dermatopathol 2011; 38: 609-15.
16. Al-Arashi MYH, Byers HR. Cutaneous clear cell squamous cell carcinoma in situ: clinical, histological and immunohistochemical characterization. J Cutan Pathol 2007; 34: 226-33. (Pubitemid 46239311)
17. Misago N, Kimura T, Toda S et al. A revaluation of trichofolliculoma: the histopathological and immunohistochemical features. Am J Dermatopathol 2010; 32: 35-43.
18. Poblet E, Jimenez-Acosta F, Rocamora A. QBEND/10 (anti-CD34 antibody) in external root sheath cells and follicular tumors. J Cutan Pathol 1994; 21: 224-8. (Pubitemid 24213235)
19. Misago N, Toda S, Narisawa Y. CD34 expression in human hair follicles and tricholemmoma: a comprehensive study. J Cutan Pathol 2011; 38: 609-15.
20. Ishida M, Kushima R, Okabe H. Immunohistochemical demonstration of D2-40 in basal cell carcinomas of the skin. J Cutan Pathol 2008; 35: 926-30.
21. Plaza JA, Ortega PF, Bengana C et al. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases. Am J Dermatopathol 2010; 32: 683-7.
22. Gomaa AH, Yaar M, Bhawan J. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics. Am J Dermatopathol 2007; 29: 18-21. (Pubitemid 46220234)
23. Mahalingam M, Hoang MP. D2-40 expression in primary scarring and nonscarring alopecia. Am J Dermatopathol 2010; 32: 427-31.
24. Schacht V, Dadras SS, Johnson LA et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 2005; 166: 913-21. (Pubitemid 40315647)
25. Herrero J, Monteagudo C, Ruiz A, Llombart-Bosch A. Malignant proliferating trichilemmal tumours: an histopathological and immunohistochemical study of three cases with DNA ploidy and morphometric evaluation. Histopathology 1998; 33: 542-6. (Pubitemid 28563380)